To prolong refractoriness or to delay conduction (or both)?
Janse
M J
MJ
Department of Clinical and Experimental Cardiology, University of Amsterdam, The Netherlands.
D000200:Action Potentials / Q000187:drug effects; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009431:Neural Conduction / Q000187:drug effects*; D015221:Potassium Channels / Q000187:drug effects*; D012032:Refractory Period, Electrophysiological / Q000187:drug effects*; D015222:Sodium Channels / Q000187:drug effects*; D013610:Tachycardia / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D015221:Potassium Channels; D015222:Sodium Channels